WhichRecall
Class IIReported 2025-09-17

Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000 Capsules per bottle, Rx Only, Manufactured by: Towa Pharmaceutical Europe, S.L., Martorelles, (Barcelona), Spain. Manufactured for: Quallent Pharmaceuticals Health LLC, Grand Cayman, Cayman Islands. NDC: 82009-030-10

Recalled by Breckenridge Pharmaceutical, Inc.

Reason for Recall

CGMP deviations: N-nitroso-duloxetine impurity above the proposed interim limit.

Advertisement
Recall Number
D-0621-2025
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2025-08-08
Reported
2025-09-17
Distribution
AZ, IN, NJ
Code Info
Lot 240927C, Exp 04/30/2027
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement